In addition, p-STAT3 and TAZ, which were identified to act downstream of FLT3, were expressed at significantly higher levels in BP-CML patients, which correlated to a large extent with FLT3 and the prognostic factors of CML (Fig. S4C). The gene discussed is STAT3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.